MedWatch

Xellia invests millions in Danish facilities

The pharmaceuticals company Xellia has invested USD 25 million in expanding the company’s largest manufacturing site in Copenhagen.

The Danish specialty pharmaceutical company Xellia is planning an expansion of its manufacturing capabilities in Copenhagen. This is according to a press release from the company.

Altogether, the company is ready to invest USD 25 million in the construction of a new multi-story building that will house “the latest sterile manufacturing equipment and containment solutions”.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier